Cytokine-Based Cancer Immunotherapies Summit Boston | Hyatt Regency Boston, MA

Kongressthemen
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/850076-3?pid=4832

Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more

https://go.evvnt.com/850076-1?pid=4832

Frau Emily Birt